moderna s covid 19 mrna vaccines (Moderna)
Structured Review
Moderna S Covid 19 Mrna Vaccines, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+covid-19+vaccine/mrna+vaccines/pmc12933839-421-6-6
Average 86 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Viral and non-viral vectors in gene therapy: current state and clinical perspectives Article Snippet: , SARS-CoV-2 Infection , National Institute of Allergy and Infectious Diseases (NIAID) , Article Title: Present and future prospects of vaccines: protecting humanity against emerging and re-emerging infectious diseases. Article Snippet: mRNA vaccines, particularly with the help of nanoparticle-based delivery systems, such as lipid nanoparticles (LNPs), have indeed enabled the successful application of Pfizer-BioNTech and Article Title: The impact of vaccine booster doses on specific B- and T-lymphocyte dynamics in Thai healthcare personnel following COVID-19 vaccination Article Snippet: This finding is consistent with other studies that have shown significant levels of S1- and RBD-specific B-lymphocytes after booster vaccinations with the Oxford-AstraZeneca, Pfizer-BioNTech, or Article Title: Vaccination against COVID-19 and Outcomes in Patients with COVID-19 Infection and Stroke Article Snippet: Compared to the unvaccinated cohort, patients who received the Article Title: COVID-19 mRNA or viral vector vaccine type and subject sex influence the SARS-CoV-2 T-cell response. Article Snippet: Severe SARS-CoV-2 infection has been partially controlled by vaccination, though issues in duration and breadth of protection remain.. Few studies investigate factors driving diversity in the cellular immune response to vaccination.. Here, we evaluated T-cell immunity in 60 healthy adults and its relationship to vaccine and subject- Article Title: Vaccination against COVID-19 and Outcomes in Patients with COVID-19 Infection and Stroke. Article Snippet: Compared to the unvaccinated cohort, patients who received the Article Title: Vaccination against COVID-19 and Outcomes in Patients with COVID-19 Infection and Stroke Article Snippet: Within the exposure cohort in TriNetX, 2460 patients received the Pfizer COVID-19 vaccine, and 997 patients received the Article Title: Article Snippet: |

